239 Stock Overview
An investment holding, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 5/6 |
Financial Health | 6/6 |
Dividends | 5/6 |
Pak Fah Yeow International Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | HK$2.35 |
52 Week High | HK$2.69 |
52 Week Low | HK$1.52 |
Beta | 0.25 |
11 Month Change | -4.47% |
3 Month Change | 10.85% |
1 Year Change | 46.88% |
33 Year Change | 28.42% |
5 Year Change | -18.97% |
Change since IPO | 403.57% |
Recent News & Updates
Recent updates
Here's Why We Think Pak Fah Yeow International (HKG:239) Might Deserve Your Attention Today
Nov 21Estimating The Intrinsic Value Of Pak Fah Yeow International Limited (HKG:239)
Aug 31Calculating The Intrinsic Value Of Pak Fah Yeow International Limited (HKG:239)
Jun 01Does Pak Fah Yeow International (HKG:239) Have A Healthy Balance Sheet?
Dec 12Pak Fah Yeow International's (HKG:239) Shareholders Will Receive A Smaller Dividend Than Last Year
Sep 02The Strong Earnings Posted By Pak Fah Yeow International (HKG:239) Are A Good Indication Of The Strength Of The Business
Sep 24Pak Fah Yeow International (HKG:239) Will Pay A Larger Dividend Than Last Year At HK$0.028
Aug 28Estimating The Intrinsic Value Of Pak Fah Yeow International Limited (HKG:239)
May 11Consider This Before Buying Pak Fah Yeow International Limited (HKG:239) For The 2.9% Dividend
Feb 21What Type Of Returns Would Pak Fah Yeow International's(HKG:239) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?
Dec 17How Does Pak Fah Yeow International Limited (HKG:239) Fare As A Dividend Stock?
Nov 21Shareholder Returns
239 | HK Pharmaceuticals | HK Market | |
---|---|---|---|
7D | -0.8% | -2.7% | -1.6% |
1Y | 46.9% | -8.3% | -2.8% |
Return vs Industry: 239 exceeded the Hong Kong Pharmaceuticals industry which returned -8.3% over the past year.
Return vs Market: 239 exceeded the Hong Kong Market which returned -2.8% over the past year.
Price Volatility
239 volatility | |
---|---|
239 Average Weekly Movement | 4.4% |
Pharmaceuticals Industry Average Movement | 5.0% |
Market Average Movement | 6.7% |
10% most volatile stocks in HK Market | 14.4% |
10% least volatile stocks in HK Market | 3.7% |
Stable Share Price: 239 has not had significant price volatility in the past 3 months.
Volatility Over Time: 239's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1927 | 102 | Wee Sean Gan | www.pakfahyeow.com |
Pak Fah Yeow International Limited, an investment holding, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name. It operates in three segments: Healthcare, Property Investments, and Treasury Investments. The company offers white flower embrocation medicated oils, strain relief products, and ointments, as well as Fúzai 239, a floral-scented white flower embrocation.
Pak Fah Yeow International Limited Fundamentals Summary
239 fundamental statistics | |
---|---|
Market cap | HK$732.35m |
Earnings (TTM) | HK$105.04m |
Revenue (TTM) | HK$259.56m |
7.0x
P/E Ratio2.8x
P/S RatioIs 239 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
239 income statement (TTM) | |
---|---|
Revenue | HK$259.56m |
Cost of Revenue | HK$40.72m |
Gross Profit | HK$218.84m |
Other Expenses | HK$113.80m |
Earnings | HK$105.04m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 0.34 |
Gross Margin | 84.31% |
Net Profit Margin | 40.47% |
Debt/Equity Ratio | 0.6% |
How did 239 perform over the long term?
See historical performance and comparison